Amir London, CEO of Israeli biotech Kamada, was interviewed on ILTV Daily about Kamada’s protein purification treatments for lung disease and rabies.  Kamada’s Glassia is also being tested for treating Type 1 diabetes, GVHD and the rejection of bone marrow and lung transplants.

https://www.youtube.com/watch?v=EX609il_5FU

https://israelactive.com/?s=kamada